Honors for Dr. Virginia LiVolsi, Dr. Zubair Baloch, and fourth-year resident Dr. Sam Wei.
Read more
The Department mourns the death of Dr. Nicholas Gonatas, Professor of Pathology and Laboratory Medicine, luminary neuropathologist, world-class researcher, founder of the Division of Neuropathology at Penn, and outstanding teacher and mentor to scores of pathology fellows, residents, graduate students, and postdoctoral fellows.
Read more
In a study that sheds light on how phospholipid signals are controlled during tumorigenesis, the Chen Lab reports that TIPE3, a newly described oncogenic protein, is the transfer protein of phosphoinositide second messengers that promote cancer.
Read more
Melanoma physicians and researchers from Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million NCI SPORE grant.
Read more
Penn's Pathology Residency Program was ranked #2 in the nation for residents with a research focus, either translational or basic, and #1 for residents interested in basic and clinical research and fellowships in Neuropathology or Transfusion Medicine. In addition, the program ranked in the top 5 for residents interested in academic careers and Hematopathology, Molecular Genetics, and Cytopathology.
Read more
Construction of a first-of-its-kind Center for Advanced Cellular Therapeutics at Penn Medicine has begun.
Read more
Rachel L. Sargent, MD, a graduate of the Residency Program, has joined the Department as Assistant Professor and Attending Physician in the Section of Hematopathology.
Read more
Dr. David Weiner is among the 2014 Top 50 "Most Influential People in Vaccines." Dr. Weiner’s research in the area of Molecular Immunology has focused extensively on the development of gene-based vaccines and immune therapies.
Read more
A drug developed by the Lambris Lab has received orphan status in Europe for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
Read more
The lab of James M. Wilson, MD, PhD, director of the Penn Gene Therapy Program, has published a proof-of-principle animal study that reduces harmful accumulation of proteins in a rare lysosomal storage disease through direct gene therapy.
Read more
Pages
